A bioequivalence study of tadalafil oral film.

Trial Profile

A bioequivalence study of tadalafil oral film.

Phase of Trial: Phase I

Latest Information Update: 02 Sep 2010

At a glance

  • Drugs Tadalafil; Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics
  • Sponsors IntelGenx Corp.
  • Most Recent Events

    • 02 Sep 2010 Results reported in an IntelGenx media release.
    • 02 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top